119 related articles for article (PubMed ID: 38452582)
1. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
3. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
4. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
[TBL] [Abstract][Full Text] [Related]
6. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
7. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation.
Stahlhut C; Slack FJ
Cell Cycle; 2015; 14(13):2171-80. PubMed ID: 25714397
[TBL] [Abstract][Full Text] [Related]
9. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
10. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.
Zhong S; Golpon H; Zardo P; Borlak J
Transl Res; 2021 Apr; 230():164-196. PubMed ID: 33253979
[TBL] [Abstract][Full Text] [Related]
11. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
12. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
[TBL] [Abstract][Full Text] [Related]
13. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
14. miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer.
Liu X; Wang X; Chai B; Wu Z; Gu Z; Zou H; Zhang H; Li Y; Sun Q; Fang W; Ma Z
Int J Biol Sci; 2022; 18(10):4187-4202. PubMed ID: 35844793
[TBL] [Abstract][Full Text] [Related]
15. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
Li Q; Wang Y; He J
J Clin Lab Anal; 2021 Jul; 35(7):e23853. PubMed ID: 34057242
[TBL] [Abstract][Full Text] [Related]
16. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
[TBL] [Abstract][Full Text] [Related]
17. PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
Naidu S; Shi L; Magee P; Middleton JD; Laganá A; Sahoo S; Leong HS; Galvin M; Frese K; Dive C; Guzzardo V; Fassan M; Garofalo M
Sci Rep; 2017 Nov; 7(1):15441. PubMed ID: 29133857
[TBL] [Abstract][Full Text] [Related]
18. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
Flamini V; Jiang WG; Cui Y
Anticancer Res; 2017 Aug; 37(8):4319-4327. PubMed ID: 28739724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]